title: [Role of pharmaceutical company pharmacist in provision of drug information for cancer chemotherapy].
abstract: Recently, oxaliplatin(L-OHP)and irinotecan hydrochloride hydrate(CPT-11)have gained recognition as key drugs in the treatment of advanced colorectal cancer. In this article, we describe the results of a survey of medical institutions by pharmacists working at a pharmaceutical company. First, questions from medical institutions on L-OHP and CPT-11 were totaled and analyzed. The results showed that most of these questions concerned safety, with many of these addressing side effects. Next, a questionnaire on FOLFOX and FOLFIRI regimens was administered to medical institutions. The results indicated that staff are interested in the safety and critical path of these regimens. These results suggest that a lot of medical institutions require more information from pharmaceutical companies. This indicates that pharmacists should do more to take the needs of medical institutions into account in providing improved customer support.
authors.affiliation: Yakult Honsha Co., Ltd.
authors.forename: Iori
authors.initials: I
authors.lastname: Koshida
authors.forename: Kenichi
authors.initials: K
authors.lastname: Kubota
authors.forename: Masaki
authors.initials: M
authors.lastname: Yamashita
authors.forename: Hideya
authors.initials: H
authors.lastname: Katayanagi
authors.forename: Kohei
authors.initials: K
authors.lastname: Noda
authors.forename: Hakaru
authors.initials: H
authors.lastname: Terada
authors.forename: Shinichi
authors.initials: S
authors.lastname: Yoshioka
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Sekine
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Kameda
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Terada
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D004345:Drug Industry; D006801:Humans; D007564:Japan; D009369:Neoplasms / Q000188:drug therapy*; D010595:Pharmacists / Q000592:standards*; D012955:Societies, Medical; D011795:Surveys and Questionnaires
chemical_list: D000970:Antineoplastic Agents